Blast crisis in chronic myeloid leukemia: An immunophenotypic analysis

نویسندگان

چکیده

Background and Aim of Study: There are two different phases untreated chronic myeloid leukemia – phase, blast crisis according to the World Health Organization classification Hematolymphoid tumors. The cells in can express myeloid, lymphoid, bi-phenotypic, monocytic, megakaryocytic, erythroid phenotypes. immunophenotype population determines how patients respond treatment, hence flowcytometric examination is required. aim study: assess immunophenotyping outcomes flowcytometry performed on crisis. Material Methods: A five-year retrospective descriptive analysis was carried out Pathology Department at King George’s Medical University Lucknow, India (2017-2021). patient’s peripheral blood bone marrow aspirate samples were analyzed. Clinical, hematological, immunophenotypic data retrieved. flow cytometry prepared using standardized “lyse-stain-wash” method. Results: total 43 cases retrieved from departmental archive 5 years. mean age study 39.62±14.86 24 males 19 females. 27 diagnosed with crisis, 14 B-lymphoid 2 mixed phenotypic acute leukemia. Conclusions: Identification lineage crucial since existence atypical phenotypes influences disease treatment prognosis.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Erythroid blast crisis of chronic myeloid leukemia.

70-year old woman was admitted with a diagnosis of pyelonephritis. The physical examination showed her to be lethargic and febrile (39°C). There was no liver or spleen enlargement. Laboratory findings were as follows: white blood cell count: 25310, hemoglobin level: 11.2 g/dL, platelet count: 41310/L, lacticodehydrogenase level: 4,100 IU/L (normal value < 350); erythrocyte sedimentation rate: 9...

متن کامل

Flow Cytometry in Chronic Myelogenous Leukemia Blast Crisis

Background: Chronic myelogenous leukemia (CML) is a myeloproliferative disorder due to BCR-ABL1 translocation. Patients showing transformation into blast crisis (BC) have poorer treatment response and prognosis.  Methods: A retrospective study was conducted in the department of Pathology, Maulana Azad Medical College, New Delhi, India, over a time period of 5 years (2014-2019) to evaluate the ...

متن کامل

Promyelocytic blast crisis of chronic myeloid leukemia during imatinib treatment.

A 32-yr-old man with the chronic phase of chronic myeloid leukemia (CML-CP) was treated with imatinib mesylate for 6 mo. The real-time quantitative reverse transcription PCR ratio for BCR/ABL in blood mRNA (BCR/ABL RT-QPCR) decreased from an initial value of 0.0159 to a low value of 0.0012 after 3 mo, indicating complete hematologic response. During the next 3 mo, the patient progressed to a pr...

متن کامل

Chronic myeloid leukemia blast crisis arises from progenitors.

Chronic myeloid leukemia (CML) progresses through three distinct clinical stages: chronic phase, accelerated phase, and blast crisis. The progression to accelerated phase and blast crisis is driven by activation of oncogenes, inactivation of tumor suppressor genes, and/or amplification of the BCR-ABL fusion gene, which causes the chronic phase of the disease. The cell of origin of blast crisis ...

متن کامل

Immunophenotypic evolution of blast populations in pediatric acute myeloid leukemia

DOI: 10.1590/S1679-45082016AI3516 Acute myeloid leukemia (AML) results from accumulation of abnormal blasts in the bone marrow, interfering with hematopoiesis.(1) Multiparametric flow cytometry is an important and well-known tool for AML diagnosis and for monitoring of minimal residual disease.(2) However, this technique is still poorly explored to elucidate clonal evolution of the leukemia. We...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: International journal of science annals

سال: 2022

ISSN: ['2617-2682', '2707-3637']

DOI: https://doi.org/10.26697/ijsa.2022.1-2.3